Transcatheter Aortic Valve Implantation for Aortic Stenosis and Subaortic Membrane
Author Information
Author(s): Tayel Hesham, Elhakim Abdelrahman, Elsoudi Mohamed, Nour Amira, Saad Mohammed
Primary Institution: Menofia University
Hypothesis
Can transcatheter aortic valve implantation (TAVI) effectively treat symptomatic aortic stenosis combined with subaortic membrane stenosis in high-risk patients?
Conclusion
TAVI is a feasible and effective treatment for patients with symptomatic aortic stenosis and subaortic membrane stenosis, especially those at high surgical risk.
Supporting Evidence
- The combination of symptomatic aortic stenosis and subaortic membrane is rare and challenging to manage.
- Transcatheter aortic valve implantation can be performed safely in high-risk patients.
- Three-month follow-up showed no complications after the procedure.
Takeaway
Doctors can use a special heart valve procedure to help older patients with a rare heart problem that makes it hard for blood to flow.
Methodology
The patient underwent transoesophageal echocardiography and transcatheter aortic valve implantation after careful evaluation by a heart team.
Potential Biases
Potential bias due to the authors' affiliations with the institutions involved in the study.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
A 78-year-old male with a history of chronic renal failure.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website